GJB1 and diabetic kidney disease: Several studies have confirmed its anti-fibrosis effect by regulating the Cx32-Nox4 signaling pathway (Chen et al., 2020a) and Nrf2-ARE anti-oxidative pathway (Huang et al., 2015; Gong et al., 2017) in DKD models.